会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • SYSTEM TO REDUCE DEFIBRILLATION REQUIREMENTS
    • 减少破坏要求的制度
    • WO1998013102A1
    • 1998-04-02
    • PCT/US1997017233
    • 1997-09-25
    • CARDIAC PACEMAKERS, INC.
    • CARDIAC PACEMAKERS, INC.KENKNIGHT, Bruce, H.
    • A61N01/39
    • A61N1/3962
    • A hybrid tachyarrhythmia therapy utilizes a combination of two therapies: pacing therapy (optionally followed by therapy employing waveforms having morphologies congruent to defibrillation waveforms but at reduced strength); and defibrillation (including cardioversion) therapy. The two therapies are applied in either a temporally concident, or an immediately sequential, fashion. At least one pacing pulse that influences only a localized portion of selected cardiac tissue is applied, prior to or coincident with at least one defibrillation-level shock. The defibrillation shock strength (voltage and/or energy) required to terminate the tachyarrhythmia is less than would be required in the absence of the critically coupled pacing pulses. The therapy may be applied to atrial or ventricular tachyarrhythmias. A variety of electrode configurations and defibrillation pulse schemes may be employed.
    • 混合性快速性心律失常治疗采用两种疗法的组合:起搏治疗(可选地采用具有与除颤波形一致的形态的波形但具有减弱的强度); 和除颤(包括心脏复律)治疗。 这两种疗法以时间上的一致性或立即顺序的方式使用。 至少一个起搏脉冲只影响所选择的心脏组织的局部部分,在与至少一个除颤级别的休克之前或之前一起应用。 终止快速性心律失常所需的除颤冲击强度(电压和/或能量)小于在不存在关键起搏脉冲的情况下所需要的。 该治疗可应用于心房或室性快速性心律失常。 可以采用各种电极配置和除颤脉冲方案。
    • 6. 发明申请
    • METHOD AND APPARATUS FOR CELL AND ELECTRICAL THERAPY OF LIVING TISSUE
    • 用于活组织的细胞和电疗法的方法和设备
    • WO2004050180A2
    • 2004-06-17
    • PCT/US2003/038085
    • 2003-11-26
    • CARDIAC PACEMAKERS, INC.
    • GIROUARD, Steven, D.SALO, Rodney, W.KENKNIGHT, Bruce, H.
    • A61N1/368
    • A61N1/368
    • A method for cell and electrical therapy of living tissue including administration of exogenous cells into a region of injured tissue and application of electrical energy. In one application the exogenous cells are conditioned in vitro before their administration into tissue. In one application the combined cell and electrical therapy is applied in vivo to damaged heart tissue. In such applications, minimally invasive procedures are used to apply the cell therapy and the electrical therapy is provided via an implantable pulse generator. In one application an implantable pacemaker is used in the VDD or DDD mode with an atrioventricular delay kept relatively short when compared to the intrinsic atrioventricular delay.
    • 一种用于活组织的细胞和电疗法的方法,包括将外源细胞施用到受损组织的区域中并施加电能。 在一个应用中,外源细胞在其施用于组织之前在体外进行条件化。 在一个应用中,组合的细胞和电疗法在体内应用于受损的心脏组织。 在这种应用中,微创手术用于应用细胞治疗,电疗通过植入式脉冲发生器提供。 在一个应用中,植入式起搏器用于VDD或DDD模式,与房室内固有延迟相比,房室延迟保持相对较短。